LYMRIT 37-01
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Nordic Nanovector ASA
Start Date
September 25, 2019
End Date
December 29, 2023
Administered By
Duke Cancer Institute
Awarded By
Nordic Nanovector ASA
Start Date
September 25, 2019
End Date
December 29, 2023